Clinical Trial Update: Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC [NA]

View source ↗

Summary

A clinical trial update shows ongoing recruitment for a study evaluating the 68Ga-DOTA-CCK-FS PET/CT imaging tracer in medullary thyroid carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medullary Thyroid Carcinoma

Drugs mentioned

• 68Ga-DOTA-CCK-FS PET/CT tracer (68Ga-DOTA-CCK-FS radiotracer for PET/CT)

Snippet

Sponsor: Luo Yaping | Conditions: Medullary Thyroid Carcinoma | NA | Status: RECRUITING